Atrial Fibrillation: New Therapeutic Concepts

Work from a November 2001 conference sponsored by Solvay Pharmaceuticals looks at recent research in the treatment of atrial fibrillation and reviews different aspects of the disorder's pathophysiology, epidemiology, and current therapy. The book evaluates progress achieved by molecular biology in recent years in identifying ion channel proteins and genetic defects related to atrial fibrillation, and highlights new avenues of current research on more effective and safer treatments. There is...